1. Home
  2. RSSS vs SERA Comparison

RSSS vs SERA Comparison

Compare RSSS & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Research Solutions Inc

RSSS

Research Solutions Inc

HOLD

Current Price

$2.57

Market Cap

86.5M

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$1.93

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSSS
SERA
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.5M
79.5M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
RSSS
SERA
Price
$2.57
$1.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
45.2K
15.9K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
130.77
32.32
EPS
0.04
N/A
Revenue
$28,793,922.00
$81,000.00
Revenue This Year
$1.81
$554.81
Revenue Next Year
$5.73
$517.27
P/E Ratio
$64.25
N/A
Revenue Growth
2.77
5.19
52 Week Low
$2.15
$1.37
52 Week High
$4.12
$4.09

Technical Indicators

Market Signals
Indicator
RSSS
SERA
Relative Strength Index (RSI) 54.11 38.70
Support Level $2.48 $1.72
Resistance Level $2.60 $2.41
Average True Range (ATR) 0.11 0.17
MACD 0.01 -0.03
Stochastic Oscillator 41.43 2.04

Price Performance

Historical Comparison
RSSS
SERA

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: